Stock analysis · Bull Rankings model

CTRE analysis

CareTrust REIT, Inc.REIT - Healthcare Facilities. Scored on the same transparent model behind the daily rankings.

CTRE
CareTrust REIT, Inc. · REIT - Healthcare Facilities
Yield4.0%B+
Rev+61.8%A
D/E0.72B+
69.4REIT strength
$39.03$9.2B
1Y Target$45.38Analyst consensus · 13 analysts
5Y Target$66.45Compound horizon
10Y Target$98.57Long-dated conviction
Yield4.0%
B+
Yield 4.0% — healthy income · REITs are valued on FFO / AFFO, which our data source doesn't provide — we grade income, growth, and sector-relative leverage instead.
Rev+61.8%
A
Revenue +61.8% — hypergrowth, top decile
D/E0.72
B+
D/E 0.72 — below the Real Estate debt median (≈40th pctile)

Forward price target — the 1-year figure is the analyst consensus where the stock is covered; the 5- and 10-year figures compound our earnings estimate from there. The DCF below is a separate cross-check on intrinsic value (what it's worth today), not another target.

Financial strength · 69.4 / 100
Profitability78.3
Value (P/B)54.8
Income79.6

A peer-relative read for reits on profitability (ROE, depreciation-adjusted), valuation, and covered income — the quality-growth (FCF/ROIC) screen doesn't apply to balance-sheet businesses. Not comparable to the 0–100 quality-growth score shown on other stocks.

Entry · Margin of safety
52-week rangeMid-range
11% off the 12-month high

Model-generatedGenerated by the Bull Rankings model from this company's reported fundamentals, and checked against the figures shown above.

Why now
REIT - Healthcare Facilities · market cap $9.2b. 11% off the 52-week high of $43.62. Revenue growing +62% — in hypergrowth territory. 13 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $45.38 (implying +16% upside).
Moat
Net margin 62% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma.
Risk
P/S 16.1x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
Horizon
1-3 yr $45.38 (13-analyst consensus) — fundamentals + valuation re-rating. 5 yr $66.45 at ~11% CAGR — compounding case rests on the competitive position widening. 10 yr $98.57 if current growth sustains into durable earnings power.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

Not enough history yet — the model records CTRE's score after each daily run, and the chart appears once a few days have accumulated.

CTRE at a glance

FINANCIAL STRENGTH · REITPROFITABILITY78VALUE55COVERED INCOME8069.4/100 on our peer scale — not the quality-growth score.
ONE-YEAR MOVE VS ITS BETAFLATThis stock+15%Trailing one-year price change. Price history is not an inputto the Bull Rankings score.
PRICE IN ITS 52-WEEK RANGE$39$32.8 LOWHIGH $43.6Trading at the 58th percentile of its 52-week range ($32.8–$43.6).

Every figure here comes from the same audited fundamentals behind the score. Charts drawn from data the score does not use say so on the card.

Analyst estimate revisions

30-day change+1.9%
90-day change+3.4%
Forward EPS estimate$1.78

Over the last 90 days, what analysts expect CTRE to earn is drifting higher (+3.4%). The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.

A rising estimate means expectations are improving, not that the price has failed to keep up — and estimates get cut as readily as they get raised. It is not part of the Bull Rankings score. Biggest movers across the market →

Shares to buy
51
Position size
$1,991
4.0% of portfolio
Stop price
$29.27
25% below $39.03
$ at risk if stopped
$497.63
budget $500.00 · 1% of portfolio

Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.

CareTrust REIT, Inc. (CTRE): score, valuation & FAQ

CareTrust REIT, Inc. (CTRE) is a REIT - Healthcare Facilities company. As a bank, insurer or REIT it runs on a different financial model from the rest of the market, so Bull Rankings grades it on a sector-appropriate card — price-to-book, dividend yield, payout ratio and cash-flow coverage — rather than the 0–100 quality-growth score used elsewhere. The read below is a transparent screen, not a buy recommendation.

Its strongest graded signals are Rev (A), Yield (B+) and D/E (B+).

Is CTRE a good stock to buy?

Bull Rankings grades CTRE on a sector-appropriate card — price-to-book, dividend yield, payout and cash-flow coverage — rather than a single quality-growth score. That is driven by Rev (A), Yield (B+) and D/E (B+). A score is a quantitative screen of CareTrust REIT, Inc.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.

How does Bull Rankings grade CTRE?

As a bank, insurer or REIT, CTRE isn't given a quality-growth score — signals like free cash flow, debt-to-equity and P/E don't translate cleanly to a balance-sheet business. Instead it's graded on a sector-appropriate card: price-to-book, dividend yield, payout ratio and operating-cash-flow coverage, where it rates strongest on Rev (A), Yield (B+) and D/E (B+).

Is CTRE overvalued or undervalued?

We don't compute a reliable discounted-cash-flow value for CTRE — typically because it is not yet consistently profitable or free-cash-flow positive — so its valuation rests on growth and price-to-sales rather than on earnings-based intrinsic value. Judge it on the trajectory of the business, not a single multiple.

What are the main risks of investing in CTRE?

P/S 16.1x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.

New to these metrics? The guides explain free cash flow, how the score works, and more in the learn hub — or run another name through the screener.

Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial advisor.

More Healthcare REITs stocks by score

All Real Estate rankings →

Analyze another ticker →